Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/21/1995 | EP0658627A2 Recombinant DNA with interferon-alpha promoter |
06/21/1995 | EP0658626A1 Methods for producing protein C |
06/21/1995 | EP0658625A2 Protein that can be biotinylated to be used for the germination stage determination |
06/21/1995 | EP0658624A2 Recombinant genes expressing pp14 |
06/21/1995 | EP0658623A2 Attenuated herpesviruses, herpesviruses which include foreign DNA encoding an amino acid sequence and vaccines containing same |
06/21/1995 | EP0658622A2 Fungi resistant to soraphen A |
06/21/1995 | EP0658621A1 Enzymatic removal of non-cibles nucleic acid from biological samples |
06/21/1995 | EP0658569A1 Method for decoloring human serum albumin |
06/21/1995 | EP0658213A1 Multiple antibiotic resistance operon assays |
06/21/1995 | EP0658212A1 Method, reagent and kit for the detection and amplification of nucleic acid sequences |
06/21/1995 | EP0658210A1 Translocation signal facilitated nuclear delivery of macromolecules |
06/21/1995 | EP0658209A1 Endothelial lineage specific transcriptional regulatory element from tek |
06/21/1995 | EP0658208A1 Novel plants and processes for obtaining them |
06/21/1995 | EP0658207A1 Improved plant germplasm |
06/21/1995 | EP0658206A1 Inhibitor resistant serine proteases |
06/21/1995 | EP0658205A1 Lipoprotein associated phospholipase a 2?, inhibitors thereof and use of the same in diagnosis and therapy |
06/21/1995 | EP0658204A1 DNA ENCODING THE HEME-REGULATED EUKARYOTIC INITIATION FACTOR 2$g(a) KINASE |
06/21/1995 | EP0658203A1 Modified fungal cells and method for producing recombinant products |
06/21/1995 | EP0658202A1 Eucaryotic cells transformed with a mammalian phospholipid kinase or protein kinase and assays using them |
06/21/1995 | EP0658201A1 Dna sequences involved in the secondary metabolite biosynthesis by myxobacteria |
06/21/1995 | EP0658200A1 Glucagon receptors |
06/21/1995 | EP0658199A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
06/21/1995 | EP0658198A1 Multicistronic expression units and their use |
06/21/1995 | EP0658197A1 Targeted replacement of a gene without endogenous and selectable residual sequences |
06/21/1995 | EP0658196A1 GENE INSERTION BY DIRECT LIGATION $i(IN VITRO) |
06/21/1995 | EP0658194A1 Mammalian multipotent neural stem cells |
06/21/1995 | EP0658193A1 ANIMAL 2-5A-DEPENDENT RNases AND ENCODING SEQUENCES THEREFOR |
06/21/1995 | EP0658170A1 Glucagon antagonists and methods for detecting glucagon antagonists |
06/21/1995 | EP0658168A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
06/21/1995 | EP0658167A1 4,7-dichlorofluorescein dyes as molecular probes |
06/21/1995 | EP0658164A1 Chromatographic purification and separation process for mixtures of nucleic acids |
06/21/1995 | EP0658119A1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate |
06/21/1995 | EP0658113A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
06/21/1995 | EP0458959B1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
06/21/1995 | EP0431171B1 Monoclonal antibody against c-reactive protein |
06/20/1995 | US5426181 DNA encoding cytokine-induced protein, TSG-14 |
06/20/1995 | US5426180 Methods of making single-stranded circular oligonucleotides |
06/20/1995 | US5426051 Plasmid containing gene and expression control region for the gene, for homologous recombination with vaccinia virus |
06/20/1995 | US5426050 Plasmid vectors for expression of genes in coryneform bacteria |
06/20/1995 | US5426048 DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor |
06/20/1995 | US5426047 Plasmid pBUL1 derived from a lactobacillus and derivatives thereof |
06/20/1995 | US5426044 Minactivin compositions and antibodies to minactivin |
06/20/1995 | US5426043 Cloning and expression of acetyl xylan esterases from fungal origin |
06/20/1995 | US5426041 Binary cryptocytotoxic method of hybrid seed production |
06/20/1995 | US5426040 Genetic engineering; DNA insertion to produce transgenic multicellular marine red algae |
06/20/1995 | US5426039 Direct molecular cloning of primer extended DNA containing an alkane diol |
06/20/1995 | US5426036 Processes for the preparation of foreign proteins in streptomycetes |
06/20/1995 | US5425936 Useful for therapeutic, prophylactic and diagnostic purposes |
06/20/1995 | CA2000114C Melanin production |
06/20/1995 | CA1335966C Kex2 endoprotease and process for production thereof |
06/20/1995 | CA1335965C Cucumber mosaic virus coat protein gene |
06/20/1995 | CA1335964C Use of psg5 as a temperature-sensitive plasmid |
06/20/1995 | CA1335963C Automated nucleic acid extractor |
06/20/1995 | CA1335962C Method of inactivating exonuclease activity |
06/20/1995 | CA1335961C End labeled nucleotide probe |
06/18/1995 | CA2138349A1 Method for decoloring human serum albumin |
06/16/1995 | CA2138101A1 Methods for producing protein c |
06/16/1995 | CA2137120A1 Recombinant dna and transformant containing the same |
06/15/1995 | WO1995016202A1 Labelling of nucleic acid analogue-peptide chimerae |
06/15/1995 | WO1995016055A1 Solution phase nucleic acid sandwich assays having reduced background noise |
06/15/1995 | WO1995016054A1 Identification of novel drugs and reagents |
06/15/1995 | WO1995016051A2 Methods and compositions for the suppression of neu mediated transformation |
06/15/1995 | WO1995016048A2 Recombinant protein production in bovine adenovirus expression vector system |
06/15/1995 | WO1995016047A1 Ethylene resistant selection system |
06/15/1995 | WO1995016046A1 Regulatory nucleic acid sequences and uses thereof |
06/15/1995 | WO1995016045A1 Construction of pasteurella heamolytica vaccines |
06/15/1995 | WO1995016044A2 Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules |
06/15/1995 | WO1995016043A1 Cloning of endothelin converting enzyme |
06/15/1995 | WO1995016042A1 Process for producing l-lysine by fermentation |
06/15/1995 | WO1995016041A1 Cytochrome p-450 monooxygenases |
06/15/1995 | WO1995016040A2 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
06/15/1995 | WO1995016039A1 Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof |
06/15/1995 | WO1995016038A2 Humanized antibodies and uses thereof |
06/15/1995 | WO1995016037A1 Anti-egf-r/anti-cd3 bispecific monoclonal antibody, method for its production and its use |
06/15/1995 | WO1995016036A2 IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF |
06/15/1995 | WO1995016035A2 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
06/15/1995 | WO1995016034A1 Mutants of bone morphogenetic proteins |
06/15/1995 | WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
06/15/1995 | WO1995016032A1 ANTISENSE NUCLEIC ACID FOR THE TREATMENT OF DISEASES IN WHICH EXPRESSION OF bFGF, PDGF-A OR PDGF-B PLAYS A PATHOGENIC ROLE |
06/15/1995 | WO1995016031A1 Method of transforming plant and vector therefor |
06/15/1995 | WO1995016027A1 Method of selecting specific bacteriophages |
06/15/1995 | WO1995016026A1 Reagents and methods for the detection of methotrexate |
06/15/1995 | WO1995015982A2 Process for generating specific antibodies |
06/15/1995 | WO1995015979A1 Pretargeting methods and compounds |
06/15/1995 | WO1995015976A1 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor |
06/15/1995 | WO1995015974A1 Protecting nucleic acids and methods of analysis |
06/15/1995 | WO1995015972A1 Compounds and methods for site-directed mutations in eukaryotic cells |
06/15/1995 | WO1995015971A2 Nucleic acid mediated electron transfer |
06/15/1995 | WO1995015970A1 Method for the immobilization of nucleic acid molecules |
06/15/1995 | WO1995015769A1 Preparation and use of immunoconjugates |
06/15/1995 | WO1995015764A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
06/15/1995 | WO1995015678A1 Agrobacterium tumefaciens transformation of musa species |
06/15/1995 | WO1995014233A3 Method of identifying hdm-2-specific antibodies |
06/15/1995 | WO1995014100A3 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
06/15/1995 | WO1995014089A3 Cck-2, a receptor tyrosine kinase |
06/15/1995 | WO1995014028A3 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
06/15/1995 | WO1995012678A3 Improvements relating to cancer therapy |
06/15/1995 | WO1995011980A3 PLASMIDS FOR EFFICIENT EXPRESSION OF SYNTHETIC GENES IN $i(E. COLI) |
06/15/1995 | WO1995011974A3 Human peroxisome proliferator activated receptor |
06/15/1995 | WO1995006129A3 Transfection process |